BNTX logo

BioNTech SE (BNTX) EBIT

Annual EBIT:

-$695.96M-$1.68B(-171.08%)
December 31, 2024

Summary

  • As of today, BNTX annual earnings before interest & taxes is -$695.96 million, with the most recent change of -$1.68 billion (-171.08%) on December 31, 2024.
  • During the last 3 years, BNTX annual EBIT has fallen by -$21.54 billion (-103.34%).
  • BNTX annual EBIT is now -103.34% below its all-time high of $20.84 billion, reached on December 31, 2021.

Performance

BNTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Quarterly EBIT:

-$452.79M-$19.80M(-4.57%)
June 30, 2025

Summary

  • As of today, BNTX quarterly earnings before interest & taxes is -$452.79 million, with the most recent change of -$19.80 million (-4.57%) on June 30, 2025.
  • Over the past year, BNTX quarterly EBIT has increased by +$411.20 million (+47.59%).
  • BNTX quarterly EBIT is now -108.03% below its all-time high of $5.64 billion, reached on March 31, 2022.

Performance

BNTX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM EBIT:

-$383.72M+$411.20M(+51.73%)
June 30, 2025

Summary

  • As of today, BNTX TTM earnings before interest & taxes is -$383.72 million, with the most recent change of +$411.20 million (+51.73%) on June 30, 2025.
  • Over the past year, BNTX TTM EBIT has dropped by -$132.08 million (-52.49%).
  • BNTX TTM EBIT is now -101.81% below its all-time high of $21.24 billion, reached on March 31, 2022.

Performance

BNTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BNTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-171.1%+47.6%-52.5%
3Y3 Years-103.3%-122.1%-102.1%
5Y5 Years-238.8%-356.8%+17.3%

BNTX EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-103.3%at low-114.0%+47.6%-102.5%+51.7%
5Y5-Year-103.3%at low-108.0%+47.6%-101.8%+51.7%
All-TimeAll-Time-103.3%at low-108.0%+47.6%-101.8%+51.7%

BNTX EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$452.79M(-4.6%)
-$383.72M(+51.7%)
Mar 2025
-
-$432.99M(-235.9%)
-$794.92M(-10.8%)
Dec 2024
-$695.96M(-171.1%)
$318.72M(+73.8%)
-$717.22M(-125.5%)
Sep 2024
-
$183.34M(+121.2%)
-$318.07M(-26.4%)
Jun 2024
-
-$863.98M(-143.2%)
-$251.64M(-253.2%)
Mar 2024
-
-$355.29M(-149.5%)
$164.28M(-87.5%)
Dec 2023
$979.17M(-93.9%)
$717.87M(+187.4%)
$1.31B(-65.9%)
Sep 2023
-
$249.77M(+155.7%)
$3.84B(-36.6%)
Jun 2023
-
-$448.06M(-156.6%)
$6.06B(-29.2%)
Mar 2023
-
$791.24M(-75.6%)
$8.55B(-36.2%)
Dec 2022
$15.97B(-23.4%)
$3.25B(+31.6%)
$13.40B(-13.0%)
Sep 2022
-
$2.47B(+20.5%)
$15.41B(-16.5%)
Jun 2022
-
$2.05B(-63.7%)
$18.44B(-13.2%)
Mar 2022
-
$5.64B(+7.3%)
$21.24B(+20.8%)
DateAnnualQuarterlyTTM
Dec 2021
$20.84B(+6958.7%)
$5.25B(-4.6%)
$17.59B(+39.8%)
Sep 2021
-
$5.50B(+13.5%)
$12.58B(+84.1%)
Jun 2021
-
$4.85B(+144.9%)
$6.83B(+262.6%)
Mar 2021
-
$1.98B(+705.3%)
$1.88B(+1325.1%)
Dec 2020
-$303.92M(-47.9%)
$245.85M(+201.6%)
-$153.82M(+66.9%)
Sep 2020
-
-$242.07M(-144.2%)
-$464.22M(-82.0%)
Jun 2020
-
-$99.12M(-69.5%)
-$255.05M(-21.9%)
Mar 2020
-
-$58.49M(+9.4%)
-$209.23M(-6.5%)
Dec 2019
-$205.43M(-197.5%)
-$64.55M(-96.3%)
-$196.47M(-47.6%)
Sep 2019
-
-$32.89M(+38.3%)
-$133.11M(-6.5%)
Jun 2019
-
-$53.30M(-16.5%)
-$124.97M(-74.4%)
Mar 2019
-
-$45.73M(-3738.9%)
-$71.67M(-176.3%)
Dec 2018
-$69.05M(+3.3%)
-$1.19M(+95.2%)
-$25.94M(-4.8%)
Sep 2018
-
-$24.75M
-$24.75M
Dec 2017
-$71.44M
-
-

FAQ

  • What is BioNTech SE annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for BioNTech SE?
  • What is BioNTech SE annual EBIT year-on-year change?
  • What is BioNTech SE quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for BioNTech SE?
  • What is BioNTech SE quarterly EBIT year-on-year change?
  • What is BioNTech SE TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for BioNTech SE?
  • What is BioNTech SE TTM EBIT year-on-year change?

What is BioNTech SE annual earnings before interest & taxes?

The current annual EBIT of BNTX is -$695.96M

What is the all-time high annual EBIT for BioNTech SE?

BioNTech SE all-time high annual earnings before interest & taxes is $20.84B

What is BioNTech SE annual EBIT year-on-year change?

Over the past year, BNTX annual earnings before interest & taxes has changed by -$1.68B (-171.08%)

What is BioNTech SE quarterly earnings before interest & taxes?

The current quarterly EBIT of BNTX is -$452.79M

What is the all-time high quarterly EBIT for BioNTech SE?

BioNTech SE all-time high quarterly earnings before interest & taxes is $5.64B

What is BioNTech SE quarterly EBIT year-on-year change?

Over the past year, BNTX quarterly earnings before interest & taxes has changed by +$411.20M (+47.59%)

What is BioNTech SE TTM earnings before interest & taxes?

The current TTM EBIT of BNTX is -$383.72M

What is the all-time high TTM EBIT for BioNTech SE?

BioNTech SE all-time high TTM earnings before interest & taxes is $21.24B

What is BioNTech SE TTM EBIT year-on-year change?

Over the past year, BNTX TTM earnings before interest & taxes has changed by -$132.08M (-52.49%)
On this page